Lactoferrin not only directly neutralizes ROS but also enhances the body’s endogenous antioxidant defenses; in a dexamethasone-induced hypertension model, it has been observed that oral administration of lactoferrin in a dose-dependent effect significantly boosted the ferric reducing antioxidant power (FRAP) in plasma, indicating an overall improvement in the body’s antioxidant capacity [43]. The gene discussed is LTF; the disease is hypertensive disorder.